Ariad founder retires
May 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ariad, harvey Berger
Dr Harvey Berger the founder of US pharma firm Ariad Pharmaceuticals has announced his decision to retire as chairman and …
Reputation gains from focussing on the patient
May 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HIV, Manuel Goncalves, Pfizer, ViiV
Since being spun-off from GSK and Pfizer, specialist HIV firm ViiV Healthcare has earned the best corporate reputation amongst patients …
Merck to test Keytruda combinations
May 8, 2015Sales and Marketing BMS, Daiichi Sankyo, Merck, Plexxikon, keytruda, pembrolizumab
Merck will be teaming up with Daiichi Sankyo’s subsidiary Plexxikon to investigate immunotherapy combinations in cancer. A collaborative clinical trial …
US Court blocks Novartis biosimilar Neupogen
May 8, 2015Sales and Marketing Neupogen, Novartis, Zarxio, biosimilar, filagrastim, filgrastim-sndz
Novartis have been temporarily prevented from marketing its biosimilar version of Amgen’s drug Neupogen in the US. Earlier this year …
New malaria vaccine found effective in adults
May 8, 2015Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria
A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …
Boardroom shuffles at GSK and Roche
May 8, 2015Medical Communications, Sales and Marketing GSK, Novartis, Roche, ViiV, changes, leadership
GlaxoSmithKline and Roche have announced the latest changes to its leadership teams as the companies regroup for the year ahead. …
New app can aid tropical disease treatment
May 8, 2015Medical Communications, Sales and Marketing Merck, app, smartphone, tropical diseases
A new smartphone app is able to automatically detect parasites in the blood and may mark a fundamental shift in …
Havas Lynx Group hires three
May 8, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HAVAS LYNX, bainton, linscott, richards
Havas Lynx Group has just bolstered its ranks with the arrival of three new senior appointments. Jon Linscott joins Tim …
Gilead buys EpiTherapeutics for $65 million
May 7, 2015Sales and Marketing EpiTherapeutics, Gilead
Gilead is clearly eyeing a future market involving epigenetics as the US firm buys Danish company EpiTherapeutics for $65 million. …
J&J hands over compassionate use reviews to academics
May 7, 2015Sales and Marketing J&J, JJ, academics, compac, eap, johnson
Johnson & Johnson has struck a ‘first-of-its-kind partnership’ with academic researchers to review requests for compassionate use of its investigational …
Alexion makes $8.4 billion Synageva purchase
May 7, 2015Research and Development, Sales and Marketing Alexion, Shire, nps, rare disease, synageva
Rare disease specialist firm Alexion is splashing out $8.4 billion to buy fellow US orphan drug developer Synageva biopharmaceuticals. The …
Pfizer names new R&D leaders
May 7, 2015Research and Development, Sales and Marketing John Lin, Michael Ehlers, Pfizer, rinat
Pfizer has confirmed two key appointments to lead its worldwide research and development organisation with immediate effect. The firm will …
Chiesi rapped for ABPI code breach
May 7, 2015Medical Communications, Sales and Marketing ABPI, Chiesi, PMCPA
Chiesi made its sales reps go through a ‘tick-box’ compliance training exercise to get the pharma industry regulator ‘off its …
Celgene appoints European haematology and oncology head
May 7, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Michael Zaiac
Swiss-based Celgene International Sàrl has appointed Michael Zaiac to the position of vice president of medical affairs for its European haematology …
Generics continue to erode GSK sales
May 6, 2015Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory
GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …
ABPI appoints head of medical affairs from GSK
May 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Jacintha Sivarajah, acha
The ABPI has appointed Dr Jacintha Sivarajah as the body’s new head of medical affairs. Reporting directly to its executive …
Lundbeck gains new chief executive from Novo Nordisk
May 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kåre Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen
Danish pharma giant Lundbeck has appointed Kåre Schultz as its new president and chief executive. Schultz (pictured) will take up …
Teva forges ahead with Mylan pursuit
May 6, 2015Sales and Marketing Mylan, Perrigo, Teva, generics
Teva has reinforced its commitment to buy Mylan despite previous rejection and only days after Mylan upped its own bid …
GSK files ultra-rare disease application with EMA
May 6, 2015Research and Development, Sales and Marketing EMA, GSK, GSK2696273, Wiskott-Aldrich syndrome, bubble boy, metachromatic leukodystrophy
GlaxoSmithKline has become the first big pharma firm to file for a European marketing authorisation for a gene therapy to …
AbbVie’s Humira meets endpoint in eye disease study
May 6, 2015Research and Development, Sales and Marketing AbbVie, FDA, Humira, Zydus Cadila, adalimumab, uveitis
In a Phase III trial AbbVie’s anti-inflammatory medicine Humira has been shown to significantly lower the risk of uncontrolled uveitis …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
